Comparison of efficacy of intralesional 5-fluorouracil alone, intralesional triamcinolone acetonide alone and intralesional triamcinolone acetonide with 5-fluorouracil in management of keloids
DOI:
https://doi.org/10.66344/jpad.30.2.2020.1390Keywords:
Intralesional 5-Fluorouracil, Keloids, Triamcinolone Acetonide.Abstract
Objective To evaluate the efficacy of intralesional 5-fluorouracil alone, intralesional triamcinolone acetonide alone and combination of intralesional triamcinolone acetonide and 5-fluorouracil in treatment of keloids. Methods Ninety patients who fulfilled the inclusion and exclusion criteria were enrolled. Patients were randomly divided into three groups of 30 each. In group A; Intralesional 5-fluorouracil (5 FU) 50 mg/ml alone was used. In group B; Intralesional triamcinolone acetonide (TAC) 40mg/dl alone was used. In group c; combination of intralesional triamcinolone acetonide 40mg/dl (0.1ml) and 5-fluorouracil 50mg/ml (0.9ml) was used, on monthly basis for 6 months. Patients were assessed for efficacy, after 6 months of the treatment. Results  Efficacy was achieved in 70 cases in which 22 were from 5 FU group, 21 were from TAC group, and 27 were from 5 FU + TAC group. Statistically significant difference was found between TAC Vs 5 FU+TAC group i.e. p-value=0.02 and between 5 FU Vs 5 FU+TAC group i.e. p-value=0.04. Conclusion The combination of 5-FU+TAC has better efficacy as compared to 5-FU alone group & TAC alone group in the management of keloids.ÂReferences
Köse O, Waseem A. Keloids and hypertrophic scars; are they two different sides of the same coin? Dermatol Surg 2008; 34: 336–46.
Bollero D, Malvasio V, Catalano F, Stella M. Negative pressure surgical management after pathological scar surgical excision: a first report. Int Wound J. 2015; 12: 17-21.
Kischer C, Brody G. Structure of the collagen nodule from hypertrophic scars and keloids. Scan Electr Microscop 1980 (Pt 3): 371-6.
Prabhu A, Sreekar H, Powar R, Uppin V. A randomized controlled trial comparing the efficacy of intralesional 5-fluorouracil versus triamcinolone acetonide in the treatment of keloids. J Sci Soc 2012; 39(1): 19.
Darougheh A, Asilian A, Shariati F. Intralesional triamcinolone alone or in combination with 5â€fluorouracil for the treatment of keloid and hypertrophic scars. Clin Experiment Dermatol 2009; 34(2): 219-23.
Davison SP, Dayan JH, Clemens MW, Sonni S, Wang A, Crane A. Efficacy of intralesional 5-fluorouracil and triamcinolone in the treatment of keloids. Aesthet Surg J 2009; 29(1): 40-6.
Wu X, Gao Z, Song N, Liu W. [Clinical study of auricular keloid treatment with both surgical excision and intralesional injection of low-dose 5-fluorouracil and corticosteroids]. Zhonghua Yi Xue Za Zhi. 2009, 89(16): 1102-05.
Alhady SM, Sivanantharajah K. Keloids in various races. A review of 175 cases. Plast Recontr surg 1969; 44(6): 564-6
Gupta S, Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology 2002; 204(2): 130-2
Sharma S, Bassi R, Gupta A. Treatment of small keloids with intralesional 5-fluorouracil alone vs. intralesional triamcinolone acetonide with 5-fluorouracil. J Pak Assoc Dermatol 2012; 22: 35-40.
Khan MA, Bashir MM, Khan FA. Intralesional triamcinolone alone and in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. J Pak Med Assoc 2014; 64(9): 1003-7.
Sagheer A,Sehzad A,Hussain I. Comparison of efficacy of intralesional 5-fluorouracil alone versus intralesional triamcinolone acetonide with 5-fluorouracil in small keloids. J Pak Assoc Dermatol 2016; 26 (4): 361-365.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
